Summary
The findings were published in leading medical journals, indicating broader potential use of the medicine.
Finerenone targets damage in the kidneys caused by high blood pressure and inflammation.
The studies involved thousands of participants across different countries.
Results suggest the drug could become a treatment option for a wider range of kidney patients.
The findings were published in leading medical journals, indicating broader potential use of the medicine.
Want to learn even more? Click here to read the full story!